NetEase, Inc.
115.88USD
-3.5700 (-2.99%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $16.21▲ | $15.63 | 7 | 2 |
| Next quarter | $15.53▼ | $15.73 | 6 | 3 |
| Current year | $61.74▼ | $65.19 | 0 | 21 |
| Next year | $72.14▲ | $71.95 | 14 | 6 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $15.54 | $12.02 | -3.52 (-22.7%) |
| 2026-03-31 | $15.39 | $17.46 | +2.07 (+13.4%) |
| 2025-12-31 | $14.12 | $10.95 | -3.17 (-22.4%) |
| 2025-09-30 | $14.81 | $14.73 | -0.08 (-0.6%) |
138 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Equal-Weight | $135 $132 | Feb 12, 2026 |
| Barclays | Maintained | Equal-Weight | $120 $135 | Nov 21, 2025 |
| Benchmark | Maintained | Buy | $145 $158 | Nov 21, 2025 |
| JP Morgan | Upgraded from Neutral | Overweight | $138 $190 | Oct 10, 2025 |
| Barclays | Maintained | Equal-Weight | $118 $120 | Aug 18, 2025 |
| JP Morgan | Downgraded from Overweight | Neutral | $135 $140 | Jul 28, 2025 |
| JP Morgan | Maintained | Overweight | $120 $135 | May 19, 2025 |
| Barclays | Maintained | Equal-Weight | $104 $118 | May 16, 2025 |
| Barclays | Maintained | Equal-Weight | $82 $104 | Feb 24, 2025 |
| Benchmark | Maintained | Buy | $105 $115 | Feb 21, 2025 |
| Morgan Stanley | Maintained | Overweight | $108 $117 | Feb 12, 2025 |
| B of A Securities | Maintained | Buy | $120 $122 | Jan 15, 2025 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $90 $108 | Jan 8, 2025 |
| Citigroup | Maintained | Buy | $108 $115 | Nov 15, 2024 |
| Benchmark | Maintained | Buy | $120 $105 | Nov 15, 2024 |
| Barclays | Maintained | Equal-Weight | $104 $82 | Aug 26, 2024 |
| B of A Securities | Maintained | Buy | $142 $120 | Aug 23, 2024 |
| Jefferies | Maintained | Buy | $126 $103 | Aug 22, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $100 | Jul 5, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $100 | Jun 27, 2024 |
| Barclays | Initiated | Equal-Weight | $104 | Jun 13, 2024 |
| Benchmark | Maintained | Buy | $144 $145 | May 24, 2024 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $120 $100 | May 23, 2024 |
| HSBC | Maintained | Buy | $130 $126 | Apr 24, 2024 |
| Morgan Stanley | Maintained | Overweight | $135 $120 | Apr 12, 2024 |
2 filings from 2 insiders · 1 buy / 1 sell over 6m
Officers and directors of NTES, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mo BinOfficer, Vice President, Finance | Sell | 716 | $120.64 | $86k | Sep 2, 2026 |
| MO BINOfficer | Grant | 716 | — | — | Aug 11, 2026 |
No analyst notes on NTES yet.
Analyst Ratings
32 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 25 | 1 | 0 | 0 | Buy1.84 |
| 1 mo ago | 6 | 25 | 1 | 0 | 0 | Buy1.84 |
| 2 mo ago | 6 | 25 | 1 | 0 | 0 | Buy1.84 |
| 3 mo ago | 6 | 24 | 1 | 0 | 0 | Buy1.84 |